Phase 2 study of RBX7455

Trial Profile

Phase 2 study of RBX7455

Phase of Trial: Phase II

Latest Information Update: 16 Jan 2018

At a glance

  • Drugs RBX 7455 (Primary)
  • Indications Clostridium-difficile-infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Jan 2018 New trial record
    • 09 Jan 2018 According to a Rebiotix media release, this study is expected to start in 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top